HedgeChatter

  • Home /
  • Tag Archives

TKMR

Tekmira Provides Corporate Update and Announces Year-End Audited 2012 Results

[at noodls] – VANCOUVER, British Columbia, March 27, 2013 (GLOBE NEWSWIRE) — Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, today announced … moreView todays social media effects on TKMRView the latest stocks trending across Twitter. Click to view dashboardSee who Tekmira is hiring next, click here to view […]

March 27, 2013 Bystocknews , Comments Off on Tekmira Provides Corporate Update and Announces Year-End Audited 2012 Results read more

Tekmira Conference Call and Webcast Advisory: Corporate Update and Year-End 2012 Financial Results

[at noodls] – VANCOUVER, B.C., March 20, 2013 (GLOBE NEWSWIRE) — Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced that it will hold … moreView todays social media effects on TKMRView the latest stocks trending across Twitter. Click to view dashboardSee who Tekmira is hiring next, click here to view […]

March 20, 2013 Bystocknews , Comments Off on Tekmira Conference Call and Webcast Advisory: Corporate Update and Year-End 2012 Financial Results read more

Tekmira Outlines Key 2013 Product Development and Corporate Milestones

[at noodls] – VANCOUVER, British Columbia, Feb. 12, 2013 (GLOBE NEWSWIRE) — Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced today … moreView todays social media effects on TKMRView the latest stocks trending across Twitter. Click to view dashboardSee who Tekmira is hiring next, click here to view […]

February 12, 2013 Bystocknews , Comments Off on Tekmira Outlines Key 2013 Product Development and Corporate Milestones read more

Tekmira to Present TKM-PLK1 Phase 1 Clinical Trial Results at AACR

[at noodls] – VANCOUVER, British Columbia, Feb. 4, 2013 (GLOBE NEWSWIRE) — Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced today that … moreView todays social media effects on TKMRView the latest stocks trending across Twitter. Click to view dashboardSee who Tekmira is hiring next, click here to view […]

February 4, 2013 Bystocknews , Comments Off on Tekmira to Present TKM-PLK1 Phase 1 Clinical Trial Results at AACR read more

Tekmira’s LNP Technology Highlighted in Peer-Reviewed Publication, Cancer Discovery

[at noodls] – VANCOUVER, British Columbia, Jan. 31, 2013 (GLOBE NEWSWIRE) — Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced today … moreView todays social media effects on TKMRView the latest stocks trending across Twitter. Click to view dashboardSee who Tekmira is hiring next, click here to view […]

January 31, 2013 Bystocknews , Comments Off on Tekmira’s LNP Technology Highlighted in Peer-Reviewed Publication, Cancer Discovery read more

Tekmira Conference Call and Webcast Advisory: Corporate Update and Third Quarter 2012 Results

[at noodls] – VANCOUVER, British Columbia, Nov. 12, 2012 (GLOBE NEWSWIRE) — Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced that it … moreView todays social media effects on TKMRView the latest stocks trending across Twitter. Click to view dashboard […]

November 13, 2012 Bystocknews , Comments Off on Tekmira Conference Call and Webcast Advisory: Corporate Update and Third Quarter 2012 Results read more

Tekmira Provides Corporate Update and Announces Third Quarter 2012 Results

[at noodls] – VANCOUVER, British Columbia, Nov. 13, 2012 (GLOBE NEWSWIRE) — Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced today … moreView todays social media effects on TKMRView the latest stocks trending across Twitter. Click to view dashboard […]

November 13, 2012 Bystocknews , Comments Off on Tekmira Provides Corporate Update and Announces Third Quarter 2012 Results read more

Tekmira and Alnylam Restructure Relationship and Settle All Litigation

[at noodls] – VANCOUVER, British Columbia, Nov. 12, 2012 (GLOBE NEWSWIRE) — Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM) today announced that it has entered into a settlement agreement with Alnylam Pharmaceuticals, … moreView todays social media effects on TKMRView the latest stocks trending across Twitter. Click to view dashboard […]

November 13, 2012 Bystocknews , Comments Off on Tekmira and Alnylam Restructure Relationship and Settle All Litigation read more